
Podcast #423 · 8 Mar 2024
Next Level Electroporation Therapy: The RadioClash Story
- Device Development
- Metastasis
- MedTech
- Immunotherapy
- Entrepreneurship
- Interventional Oncology (IO)
- Interventional Radiology (IR)
- Irreversible Electroporation (IRE)
In this episode of the BackTable Podcast, host Dr. Aaron Fritts interviews guest Dr. John Qiao about exploration of physicians’ role in medical innovation, particularly among interventional radiologists.
Timestamps
Resources
- RadioClash website
- News Article on Dr. John Qiao
- Radiation Therapy as a Modality to Create Abscopal Effects: Current and Future Practices
- The Abscopal Effect: A Reemerging Field of Interest
- BackTable VI Episode #402 - Immunotherapy in HCC: Evolving Treatment Paradigms
- Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (Keynote-695)
- PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
- Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: Outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 Patients
- The improvement of irreversible electroporation therapy using saline-irrigated electrodes: a theoretical study (Northwestern study)
- Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
More about this episode
Dr. Qiao shares insightful information about the origin of RadioClash and details his journey as an entrepreneur. Through this discussion, Dr. Qiao covers the challenges encountered during the startup phase, the invention of a single-probe electroporation device, and the future applications of this novel medical technology. The episode concludes with broader advice on how to manage the demands of professional work, entrepreneurship, and personal life.

